Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Dec;79(24):7909–7913. doi: 10.1073/pnas.79.24.7909

Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro.

P Brazeau, N Ling, P Böhlen, F Esch, S Y Ying, R Guillemin
PMCID: PMC347459  PMID: 6130528

Abstract

Purified (rat) hypothalamic growth hormone releasing factor (GRF), native human GRF isolated from an islet cell tumor of the pancreas that had caused acromegaly, and the synthetic replicates of the human material are potent secretagogues of immunoreactive growth hormone (GH) by primary cultures of rat pituitary cells. Native or synthetic peptides give identical dose-response curves, with identical slopes and identical maximal effects. The median effective dose of the tumor-derived GRF is 15 x 10(-12) M. The effect of hypothalamic GRF or of a synthetic replicate of tumor-derived GRF is immediate, being demonstrable in less than or equal to 30 sec after contact in a pituitary cell perifusion system. The effect of hypothalamic GRF or of tumor-derived GRF is highly specific for stimulating release of immunoreactive growth hormone; there is no demonstrable concomitant effect on the secretion of other pituitary hormones. Somatostatin-28 and somatostatin-14 inhibit the release of growth hormone produced by hypothalamic GRF or tumor-derived GRF in typical noncompetitive antagonism. On the basis of the results reported here, hypothalamic GRF and tumor-derived GRF are qualitatively indistinguishable in their ability to stimulate the secretion of immunoreactive growth hormone in vitro. The name "somatocrinin" is proposed to replace the acronym GRF.

Full text

PDF
7909

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brazeau P., Ling N., Esch F., Böhlen P., Benoit R., Guillemin R. High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regul Pept. 1981 Jan;1(4):255–264. doi: 10.1016/0167-0115(81)90048-3. [DOI] [PubMed] [Google Scholar]
  2. Cronin M. J., Rogol A. D., Dabney L. G., Thorner M. O. Selective growth hormone and cyclic AMP stimulating activity is present in human pancreatic islet cell tumor. J Clin Endocrinol Metab. 1982 Aug;55(2):381–383. doi: 10.1210/jcem-55-2-381. [DOI] [PubMed] [Google Scholar]
  3. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  4. Drouin J., De Léan A., Rainville D., Lachance R., Labrie F. Characteristics of the interaction between thyrotropin-releasing hormone and somatostatin for thyrotropin and prolactin release. Endocrinology. 1976 Feb;98(2):514–521. doi: 10.1210/endo-98-2-514. [DOI] [PubMed] [Google Scholar]
  5. Frohman L. A., Szabo M., Berelowitz M., Stachura M. E. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest. 1980 Jan;65(1):43–54. doi: 10.1172/JCI109658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Guillemin R., Brazeau P., Böhlen P., Esch F., Ling N., Wehrenberg W. B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982 Nov 5;218(4572):585–587. doi: 10.1126/science.6812220. [DOI] [PubMed] [Google Scholar]
  7. Guillemin R., Ling N., Vargo T. Radioimmunoassays for alpha-endorphin and beta-endorphin. Biochem Biophys Res Commun. 1977 Jul 11;77(1):361–366. doi: 10.1016/s0006-291x(77)80205-2. [DOI] [PubMed] [Google Scholar]
  8. Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hirose T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature. 1982 Jul 15;298(5871):245–249. doi: 10.1038/298245a0. [DOI] [PubMed] [Google Scholar]
  9. Ling N., Esch F., Davis D., Mercado M., Regno M., Bohlen P., Brazeau P., Guillemin R. Solid phase synthesis of somatostatin-28. Biochem Biophys Res Commun. 1980 Aug 14;95(3):945–951. doi: 10.1016/0006-291x(80)91564-8. [DOI] [PubMed] [Google Scholar]
  10. Minamino N., Kangawa K., Fukuda A., Matsuo H., Iagarashi M. A new opioid octapeptide related to dynorphin from porcine hypothalamus. Biochem Biophys Res Commun. 1980 Aug 29;95(4):1475–1481. doi: 10.1016/s0006-291x(80)80063-5. [DOI] [PubMed] [Google Scholar]
  11. Reyl F. J., Lewin M. J. Intracellular receptor for somatostatin in gastric mucosal cells: decomposition and reconstitution of somatostatin-stimulated phosphoprotein phosphatases. Proc Natl Acad Sci U S A. 1982 Feb;79(4):978–982. doi: 10.1073/pnas.79.4.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  13. Saeed uz Zafar M., Mellinger R. C., Fine G., Szabo M., Frohman L. A. Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity. J Clin Endocrinol Metab. 1979 Jan;48(1):66–71. doi: 10.1210/jcem-48-1-66. [DOI] [PubMed] [Google Scholar]
  14. Sinha Y. N., Selby F. W., Lewis U. J., VanderLaan W. P. Studies of GH secretion in mice by a homologous radioimmunoassay for mouse GH. Endocrinology. 1972 Sep;91(3):784–792. doi: 10.1210/endo-91-3-784. [DOI] [PubMed] [Google Scholar]
  15. Szabo M., Chu L., Frohman L. A. Biological effects of an ectopic growth hormone-releasing peptide in cultured adenohypophyseal cells: comparison with growth hormone-releasing activity of porcine hypothalamus. Endocrinology. 1982 Oct;111(4):1235–1240. doi: 10.1210/endo-111-4-1235. [DOI] [PubMed] [Google Scholar]
  16. Vale W., Rivier C., Brazeau P., Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology. 1974 Oct;95(4):968–977. doi: 10.1210/endo-95-4-968. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES